Répertoire des subventions financées

Filtrer par

667 ésultat(s) trouvé(s)

Dissecting the shared origins of schizophrenia and chronic cannabis use: A genomic investigation

  • Type de subvention

    Capacity building grants

  • Compétition

    Rising Stars Trainee Awards

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $10,000

Characterization and modulation of the endocannabinoid system for treating Fragile X Syndrome

  • Type de subvention

    Capacity building grants

  • Compétition

    Rising Stars Trainee Awards

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $10,000

EDITINGSCHOOL and Symposium for GABA and Advanced Magnetic Resonance Spectroscopy

  • Type de subvention

    Capacity building grants

  • Compétition

    Rising Stars Trainee Awards

  • Province

    Alberta

  • Date de Début

    2024

  • Montant total du financement

    $2,744

Aperçu du projet

The 8th annual EDITINGSCHOOL and Symposium for GABA and Advanced Magnetic Resonance Spectroscopy (MRS) will take place November 18-22nd in Playa Del Carmen Mexico. The 5-day course represents a merging of a symposium focused on the development and application of advanced MRS (a niche research field) as well as the…

The Impact of Paediatric Brain Tumor Treatment on Structural and Functional Brain Connectivity

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Cancer

  • Disease Area

    Brain Cancer

  • Compétition

    CRS Doctoral Research Awards

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $70,000

  • Contribution Santé Canada

    $35,000

Developing a “one-two punch” treatment paradigm for targeting glioblastoma

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Cancer

  • Disease Area

    Brain Cancer

  • Compétition

    CRS Doctoral Research Awards

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $70,000

  • Contribution Santé Canada

    $35,000

Aperçu du projet

Glioblastoma (GBM) is the most common and aggressive form of adult brain cancer. Despite maximal surgical resection and multi-modal chemoradiation therapy, patients with GBM unfortunately have a median survival of just 15-18 months and a dismal 5-year survival rate of 5%. Development of effective treatments are challenged by the tumour’s…